Physician profile
Timothy Mcshane
NPI 1275153967
$2,689.86
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,052 · 2022: $876 · 2023: $571 · 2024: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.50 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $786.41 | 2021-2024 | Caplyta |
| Abbvie INC. | $403.93 | 2021-2023 | |
| Alkermes, INC. | $353.57 | 2021-2024 | Lybalvi, Aristada, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $263.28 | 2021-2024 | Rexulti, Abilify Mycite, Abilify Maintena |
| Lundbeck LLC | $202.82 | 2021-2023 | Rexulti |
| Neurocrine Biosciences, INC. | $133.39 | 2021-2024 | Ingrezza |
| Noven Therapeutics, LLC | $124.83 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.95 | 2021-2022 | |
| Uswm, LLC | $55.71 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $48.56 | 2021 | |
| Axsome Therapeutics, INC. | $44.35 | 2022-2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $42.80 | 2023 | Fanapt, Hetlioz |
| Neos Therapeutics, LP | $39.77 | 2021-2022 | |
| Tris Pharma INC | $25.59 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.49 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $15.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.80 | 2021 | |
| Bausch Health US, LLC | $13.39 | 2021 | |
| Ironshore Pharmaceuticals INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mcshane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.